GENPHARM SERVICES

"Your Partner of Choice and your gate to the Middle East and North Africa (MENA) Pharmaceutical World"

ABOUT US

Genpharm Services is a financially sound privately owned company based in the Dubai Science Park (DSP), U.A.E. We provide fast-track Market Access to specialty pharmaceutical companies looking to expand into the Middle East and North Africa (MENA) region. We focus on innovative and orphan drugs in areas of unmet medical needs, rare genetic disorders and autoimmune diseases.

Pharmaceutical Strategic Advice

"We also provide Management Consultancy for companies aiming at expanding directly into this dynamic region of high growth. We advise on strategies, structures and operating business models in line with the respective company priorities and portfolio. "

The global theme for Rare Disease Day 2018 is research.

There are over 6000 rare diseases, an estimated 30 million people living with a rare disease in Europe and 300 million worldwide, but no cures and few treatments available for the majority of these diseases. Rare Disease Day 2018 offers participants the opportunity to be part of a global call on policy makers, researchers, companies and healthcare professionals to increasingly and more effectively involve patients in rare disease research.

His Excellency Sheikh Nahyan bin Mubarak Al Nahyan honoring Genpharm for their role in raising awareness on Rare Diseases and for their contribution on Rare Disease Day

His Excellency Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Culture and the development of knowledge, president of the UAE Genetic Diseases Association, honored several specialized experts in rare diseases, as part of the annual Emirates International Award for reducing genetic diseases "rare disease category" in its third session.

Aspire Educational Series: OlivoPontoCerebellar Atrophy (OPCA)- Part 22

Olivopontocerebellar atrophy can be passed down through families (inherited form), or it may affect people without a known family history (sporadic form). Researchers have identified certain genes that are involved in the inherited form of this condition. In this disease brain cell of the particular part of brain namely the pons, cerebellum and inferior olive begin to degenerate and die.

Genpharm Awarded for the Second Consecutive Year, the Best MENA Pharmaceutical Company for 2017